197 related articles for article (PubMed ID: 8783582)
41. [Regional isolated perfusion: also applicable in elderly patients].
Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
Ned Tijdschr Geneeskd; 2003 Mar; 147(12):529-33. PubMed ID: 12693077
[TBL] [Abstract][Full Text] [Related]
42. Isolated limb perfusion: what is the evidence for its use?
Noorda EM; Vrouenraets BC; Nieweg OE; Van Coevorden F; Kroon BB
Ann Surg Oncol; 2004 Sep; 11(9):837-45. PubMed ID: 15313738
[TBL] [Abstract][Full Text] [Related]
43. The success of TNF alpha in isolated limb perfusion for irresectable extremity soft tissue sarcomas, melanoma and carcinomas: observations in patients and preclinical perfusion models.
Eggermont AM
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1357-70. PubMed ID: 8854755
[No Abstract] [Full Text] [Related]
44. [Treatment of melanoma of the skin with regional metastases].
Bazhenova AP; Romanova OA; Papliian NP
Khirurgiia (Mosk); 1983 Nov; (11):18-22. PubMed ID: 6664002
[No Abstract] [Full Text] [Related]
45. Natural history and selective management of in transit melanoma.
Wong JH; Cagle LA; Kopald KH; Swisher SG; Morton DL
J Surg Oncol; 1990 Jul; 44(3):146-50. PubMed ID: 2370798
[TBL] [Abstract][Full Text] [Related]
46. [Regional perfusion therapy of malignant tumors of the extremities].
Boeckl O; Hell E; Zimmermann G
Dtsch Med Wochenschr; 1970 Mar; 95(13):707-10. PubMed ID: 4985407
[No Abstract] [Full Text] [Related]
47. Isolated limb perfusion for melanoma patients--a review of its indications and the role of tumour necrosis factor-alpha.
Grünhagen DJ; de Wilt JH; van Geel AN; Eggermont AM
Eur J Surg Oncol; 2006 May; 32(4):371-80. PubMed ID: 16520016
[TBL] [Abstract][Full Text] [Related]
48. The European approach to in-transit melanoma lesions.
Hoekstra HJ
Int J Hyperthermia; 2008 May; 24(3):227-37. PubMed ID: 18393001
[TBL] [Abstract][Full Text] [Related]
49. Prognosis and determinants of outcome following locoregional or distant recurrence in patients with cutaneous melanoma.
Francken AB; Accortt NA; Shaw HM; Wiener M; Soong SJ; Hoekstra HJ; Thompson JF
Ann Surg Oncol; 2008 May; 15(5):1476-84. PubMed ID: 18196345
[TBL] [Abstract][Full Text] [Related]
50. Isolated limb perfusion for malignant melanoma.
Rosin RD; Westbury G
Practitioner; 1980 Oct; 224(1348):1031-6. PubMed ID: 7220430
[No Abstract] [Full Text] [Related]
51. Discussion. Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.
J Am Coll Surg; 2011 Aug; 213(2):317-8. PubMed ID: 21787989
[No Abstract] [Full Text] [Related]
52. Current treatment of locoregional recurrence of melanoma.
Squires MH; Delman KA
Curr Oncol Rep; 2013 Oct; 15(5):465-72. PubMed ID: 23907518
[TBL] [Abstract][Full Text] [Related]
53. [Leakage measurements with the dye extraction method and direct methotrexate level determination (enzyme immunoassay) during and after regional cytostatic limb perfusion].
Krauss J; Krause G; Hellthaler G
Z Exp Chir Transplant Kunstliche Organe; 1989; 22(4):260-3. PubMed ID: 2675480
[TBL] [Abstract][Full Text] [Related]
54. Factors predictive of acute regional toxicity after isolated limb infusion with melphalan and actinomycin D in melanoma patients.
Kroon HM; Moncrieff M; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1184-92. PubMed ID: 19224289
[TBL] [Abstract][Full Text] [Related]
55. Predictors of outcome after hyperthermic isolated limb perfusion: role of tumor response.
Aloia TA; Grubbs E; Onaitis M; Mosca PJ; Cheng TY; Seigler H; Tyler DS
Arch Surg; 2005 Nov; 140(11):1115-20. PubMed ID: 16301451
[TBL] [Abstract][Full Text] [Related]
56. Current status of isolated limb infusion with mild hyperthermia for melanoma.
Thompson JF; Kam PC
Int J Hyperthermia; 2008 May; 24(3):219-25. PubMed ID: 18393000
[TBL] [Abstract][Full Text] [Related]
57. Local and intralesional therapy of in-transit melanoma metastases.
Testori A; Faries MB; Thompson JF; Pennacchioli E; Deroose JP; van Geel AN; Verhoef C; Verrecchia F; Soteldo J
J Surg Oncol; 2011 Sep; 104(4):391-6. PubMed ID: 21858834
[TBL] [Abstract][Full Text] [Related]
58. Isolated limb infusion as palliative treatment for advanced limb disease in patients with AJCC stage IV melanoma.
Kroon HM; Lin DY; Kam PC; Thompson JF
Ann Surg Oncol; 2009 May; 16(5):1193-201. PubMed ID: 19224288
[TBL] [Abstract][Full Text] [Related]
59. Hyperthermic perfusion for melanoma of the extremities: experience with 165 patients, 1967 to 1979.
Stehlin JS
Ann N Y Acad Sci; 1980; 335():352-5. PubMed ID: 6931528
[No Abstract] [Full Text] [Related]
60. Prolonged untreated and treated course of a malignant melanoma.
Nashan D; Haufs MG; Kleinheinz J; Al-Dandashi C; Bruckner-Tuderman L
Dermatology; 2006; 212(1):93-5. PubMed ID: 16319486
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
